ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,425,000 | -93.5% | 384,995 | -88.7% | 0.21% | -92.1% |
| Q2 2021 | $83,155,000 | +147.5% | 3,409,410 | +161.8% | 2.61% | +154.0% |
| Q1 2021 | $33,595,000 | -58.9% | 1,302,129 | -14.9% | 1.03% | -64.3% |
| Q4 2020 | $81,765,000 | +370.7% | 1,529,474 | +263.2% | 2.88% | +258.3% |
| Q3 2020 | $17,370,000 | +86.4% | 421,087 | +43.4% | 0.80% | +268.3% |
| Q4 2014 | $9,321,000 | -32.9% | 293,565 | -47.7% | 0.22% | -31.9% |
| Q3 2014 | $13,885,000 | -62.3% | 560,786 | -65.6% | 0.32% | -56.6% |
| Q2 2014 | $36,871,000 | -3.1% | 1,632,175 | +4.4% | 0.74% | +6.8% |
| Q1 2014 | $38,038,000 | – | 1,563,435 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |